Merck & Co., Inc. is 282.2x more valuable than Savara Inc by market capitalization ($293.16 B vs $1.04 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | SVRA | MRK |
|---|---|---|
| Market cap | $1.04 B | $293.16 B |
| US-listed rank | #2602 | #44 |
| Revenue (latest FY) | $257.00K | $65.01B |
| Net income (latest FY) | -$118.84M | $18.25B |
| Net margin | -46240.1% | 28.1% |
| P/E (trailing FY) | - | 16.1 |
| SEC filings | 1,331 | 996 |
Merck & Co., Inc. is 282.2x more valuable than Savara Inc by market capitalization ($293.16 B vs $1.04 B).
In their latest fiscal years, Savara Inc reported $257.00K in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: Savara Inc and Merck & Co., Inc., or browse the full rankings.